Naturally occurring glucokinase mutations at the same amino acid residue cause opposite clinical phenotypes of hypo- and hyperglycaemia

Naturally occurring glucokinase mutations at the same amino acid residue cause opposite clinical phenotypes of hypo- and hyperglycaemia

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Beer, N, Tribble, N, Colclough, K, Arundel, P, Grimsby, J, Chik, C, Ellard, S, Gloyn, A
Formáid:	Conference item
Foilsithe / Cruthaithe:	2010

Míreanna comhchosúla

Discovery of a novel site regulating glucokinase activity following characterization of a new mutation causing hyperinsulinemic hypoglycemia in humans.
de réir: Beer, N, et al.
Foilsithe / Cruthaithe: (2011)

Investigating novel mutational mechanisms for glucokinase mutations with near normal or paradoxical kinetics
de réir: Tribble, N, et al.
Foilsithe / Cruthaithe: (2009)

Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation.
de réir: Ding, S, et al.
Foilsithe / Cruthaithe: (2010)

Functional characterisation of the glucokinase regulatory protein gene variant P446L shows diminished regulation by fructose-6 phosphate resulting in increased glucokinase activity
de réir: Beer, N, et al.
Foilsithe / Cruthaithe: (2009)

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
de réir: Osbak, K, et al.
Foilsithe / Cruthaithe: (2009)

Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
de réir: Turkkahraman, D, et al.
Foilsithe / Cruthaithe: (2008)

Insights into biochemical and genetical basis of glucokinase activation from naturally occuring hypoglycaemia mutations
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2003)

Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2003)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
de réir: Thomson, K, et al.
Foilsithe / Cruthaithe: (2003)

Identification and functional characterisation of novel inactivating glucokinase mutations causing GCK-MODY in Slovakia
de réir: Valentinova, L, et al.
Foilsithe / Cruthaithe: (2011)

Glucokinase (GCK) and other susceptibility genes for beta-cell dysfunction: the candidate approach.
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2008)

The role of genetic variation in glucokinase and glucokinase regulatory protein in diabetes and related traits
de réir: Beer, N, et al.
Foilsithe / Cruthaithe: (2011)

Identification of a novel beta cell glucokinase (GCK) promoter mutation (-71 G > C) which reduces promoter activity
de réir: Gasperikova, D, et al.
Foilsithe / Cruthaithe: (2008)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
de réir: Valentinova, L, et al.
Foilsithe / Cruthaithe: (2012)

The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.
de réir: Beer, N, et al.
Foilsithe / Cruthaithe: (2009)

Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2002)

Gene duplications resulting in over expression of glucokinase are not a common cause of hypoglycaemia of infancy in humans.
de réir: van de Bunt, M, et al.
Foilsithe / Cruthaithe: (2008)

Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia.
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2009)

Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
de réir: Christesen, H, et al.
Foilsithe / Cruthaithe: (2008)

Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
de réir: Lucia Valentínová, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2007)

Identification of a Novel beta-Cell Glucokinase (GCK) Promoter Mutation (-71G > C) That Modulates GCK Gene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in Humans
de réir: Gasperikova, D, et al.
Foilsithe / Cruthaithe: (2009)

Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.
de réir: Gasperíková, D, et al.
Foilsithe / Cruthaithe: (2009)

Insights into glucokinase regulatory protein regulation from the cellular and kinetic characterisation of rare coding variants
de réir: Rees, MG, et al.
Foilsithe / Cruthaithe: (2010)

Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment
de réir: S Schnyder, et al.
Foilsithe / Cruthaithe: (2005-06-01)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease
de réir: Rees, MG, et al.
Foilsithe / Cruthaithe: (2014)

A panel of diverse assays to interrogate the interaction between glucokinase and glucokinase regulatory protein, two vital proteins in human disease.
de réir: Matthew G Rees, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Elucidating the Glucokinase Activating Potentials of Naturally Occurring Prenylated Flavonoids: An Explicit Computational Approach
de réir: Kolade Olatubosun Faloye, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Small molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?
de réir: Rees, MG, et al.
Foilsithe / Cruthaithe: (2013)

Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?
de réir: Rees, MG, et al.
Foilsithe / Cruthaithe: (2014)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
de réir: Gloyn, A
Foilsithe / Cruthaithe: (2003)

Phenotypic heterogeneity in a family with a novel activating glucokinase (GCK) mutation (G68V) causing familial persistent hyperinsulinaemic hypoglycaemia of infancy
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2007)

Hypo-efficient domination and hypo-unique domination
de réir: V‎. ‎Samodivkin
Foilsithe / Cruthaithe: (2016-06-01)

Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2005)

Glucocorticoid induced hyperglycaemia
de réir: M I Weerakkody, et al.
Foilsithe / Cruthaithe: (2012-05-01)

Traffickers and Victims: Opposite sides of the same coin?
de réir: Helen Leung, et al.
Foilsithe / Cruthaithe: (2022-04-01)

A comprehensive map of human glucokinase variant activity
de réir: Sarah Gersing, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes.
de réir: Rees, MG, et al.
Foilsithe / Cruthaithe: (2012)

Persistent hyperinsulinemic hypoglycemia in a 7 yr old girl due to a novel activating glucokinase mutation
de réir: Lahr, G, et al.
Foilsithe / Cruthaithe: (2007)

Perioperative hyperglycaemia
de réir: B.M. Gardner
Foilsithe / Cruthaithe: (2012-06-01)